Introduction Major depressive disorder (MDD) is a global psychiatric disorder with no
established biomarker. There is growing evidence that functional near-infrared spectroscopy …

The acute treatment duration for major depressive disorder (MDD) is 8 weeks or more.
Treatment of patients with MDD without predictors of treatment response and future …

The neuroimaging has been applied in the study of pathophysiology in major depressive
disorder (MDD). In this review article, several kinds of methodologies of neuroimaging would …

The neuroimaging is an important tool for understanding the biomarkers and predicting
treatment responses in major depressive disorder (MDD). The potential biomarkers and …

The reduction in the oxygenation dynamics in the prefrontal cortex (PFC) during cognitive
tasks is a well-known occurrence in major depressive disorders (MDD). Studies focusing on …

Multichannel functional near-infrared spectroscopy (fNIRS) is a tool used to capture changes
in cerebral blood flow. A consistent result for depression is a decrease in blood flow in the …

Neuroimaging studies have indicated that the altered functional connectivity (FC) of the
subgenual anterior cingulate cortex (sgACC) might be potential pathophysiology of major …

Alzheimer's disease is characterized by the progressive deterioration of cognitive abilities
particularly working memory while mild cognitive impairment (MCI) represents its prodrome …

Objective Numerous studies have identified hemodynamic changes in adults with major
depressive disorder (MDD) by using functional near-infrared spectroscopy (fNIRS) …

Objective: There is lack of accurate methods to diagnose Major Depressive Disorder (MDD),
one of the most prevalent global psychiatric disorders. Possible pathophysiological effects …